Systemic hormone replacement therapy
Systemic hormone replacement therapy has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 29, 2026: “Hormonal influences on overactive bladder in women: Pathophysiology and the role of estrogen therapy”.
1 paper studies it2 findingsUpdated
1 new paper in 30 daysSee all 1 papers on systemic hormone replacement therapy
What did studies of systemic hormone replacement therapy find?
1Studies of systemic hormone replacement therapy measured one outcome, urinary incontinence.
Urinary incontinence
upin humans1
1 study
Urinary incontinence
upin humans1
Systemic hormone replacement therapy increases urinary incontinence in humans.
“systemic hormone replacement therapy—particularly with conjugated equine estrogens—worsens incontinence”
Reviewfemales
Hormonal influences on overactive bladder in women: Pathophysiology and the role of estrogen therapy
Journal für Gynäkologische Endokrinologie/Schweiz
What is systemic hormone replacement therapy linked with?
1Studies link systemic hormone replacement therapy with new-onset urinary incontinence.
New-onset urinary incontinence
upin humans1
1 study
New-onset urinary incontinence
upin humans1
Systemic hormone replacement therapy raises the risk of new-onset urinary incontinence in humans.
“according to large randomized studies (HERS, WHI) and a Cochrane Review, increases the risk of new-onset urinary incontinence”
Reviewfemales
Hormonal influences on overactive bladder in women: Pathophysiology and the role of estrogen therapy
Journal für Gynäkologische Endokrinologie/Schweiz